Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAura Egy Regulatory News (AURA)

Share Price Information for Aura Egy (AURA)

Share Price is delayed by 15 minutes
Get Live Data
5.75    -0.05 (-0.86%)
Bid:
5.50
Ask:
6.00
Spread: 0.50 (9.091%)
Market Cap: £58.62m
AURA Live PriceLast checked at - London Stock Exchange

Intraday Aura Egy Share Chart

Firm commitments for A$8.8 million placement

14 Mar 2022 07:00

RNS Number : 6369E
Aura Energy Limited
14 March 2022
 

 

14 MARCH 2022

Aura receives firm commitments for A$8.8 million placement to advance Tiris Uranium Project

KEY POINTS:

· Aura has received firm commitments to raise A$8.8 million (before costs) via a placement to sophisticated and institutional investors (the "Placement").

· The Placement was well supported by existing shareholders and several new institutional investors from Australia and overseas, including Canada and the United Kingdom.

· Funds will be used to advance Aura's flagship Low CAPEX, Low OPEX Tiris Uranium Project, including completion of the planned Resource Enhancement Program and commencement of engineering towards a decision to proceed in Q4 2022.

 

Aura Energy Limited (ASX:AEE, AIM:AURA) ("Aura", the "Company") is pleased to announce that it has received firm commitments to raise approximately A$8.8 million (before costs) via an oversubscribed share placement to institutional, sophisticated and professional investors ("Placement"), at an issue price of $0.25 per share, representing a 20% discount to the Company's 5-day volume weighted average price (VWAP).

Commenting on the completion of the Placement, acting CEO Dr Will Goodall said:

"I am very pleased with the support shown from existing and new shareholders in this placement. The uranium market is strong, reflecting the rapidly emerging understanding of the critical role that nuclear energy will play in the energy mix of a Net Zero Emission world. The geopolitical situation will continue to introduce some volatility, however the fundamental lack of primary supply in the uranium market should continue to underpin a strengthening position for near term development projects, such as Aura's Tiris Project."

"In this placement we have seen very strong support from existing shareholders and a strengthening of key institutions on our register, in both Australia, the United Kingdom and Canada. The funds raised will allow us to complete the resource enhancement program at Tiris as announced on 9 February 2022, and importantly will also allow us to commence the engineering phase for the Tiris Project, securing an Engineering Consultant and initiating the Front End Engineering Design (FEED) study, progressing us towards a decision to mine in Q4 2022."

"The remainder of this year will see Aura rapidly progress the Low CAPEX, Low Operating cost Tiris Uranium Project. We plan to enhance and expand the Tiris resource, finalise regulatory discussions with the Mauritanian government, progress marketing and financing conversations and take engineering to a point where we can move into procurement and construction through 2023. We are excited by the journey and look forward to bringing the Tiris Project to a stage where we are producing uranium, supporting the global push to minimise carbon emissions."

Shareholder approval for the Placement was obtained at the Annual General Meeting held on 21 December 2021. The Placement will comprise the issue of approximately 35.2 million new shares in the Company ("New Shares") at an issue price of A$0.25 per New Share and represents a 20% discount to the Company's 5-day volume weighted average price (VWAP) of existing ordinary shares ("Ordinary Shares"). New Shares issued under the Placement will rank equally with existing fully paid Ordinary Shares.

Aura proposes to use funds from the Placement (after administration costs) predominantly on advancing the Company's Tiris Project as set out the following use of funds of table:

Use of funds

Funds Raised

Tiris Uranium Project

$7,600,000

Corporate costs (including capital raising cost) 

$508,000

General working capital

$692,000

Total

$8,800,000

PAC Partners Securities Pty Ltd ("Pac Partners") acted as Lead Manager to the Placement.

The New Shares are expected to be issued on 18 March 2022, with quotation on the ASX on 21 March 2022.

This announcement is intended to lift the current ASX trading halt placed on the Company's securities.

 

This ASX Release as authorised by the Aura Energy Board of Directors. 

 

For Further Information, please contact: 

Will Goodall 

Acting CEO 

Aura Energy Limited 

info@auraenergy.com.au  

 

Jane Morgan 

JMM 

Investor & Media Relations 

info@janemorganmanagement.com.au 

+61 405 555 618 

 

SP Angel Corporate Finance LLP

(Nominated Advisor and Joint Broker)

David Hignell

Kasia Brzozowska

Telephone: +44 (0) 203 470 0470

WH Ireland Limited(Joint Broker)

Jessica Cave

Andrew de Andrade

+44 (0) 207 220 1666

 

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ('MAR'). Upon the publication of this announcement via Regulatory Information Service ('RIS'), this inside information is now considered to be in the public domain.

 

About Aura Energy (ASX:AEE, AIM:AURA)

Aura Energy is an Australian based minerals company that has major uranium and polymetallic projects with large resources in Africa and Europe. The Company is focused on resource expansion and uranium production at the Tiris Project, a major greenfields uranium discovery in Mauritania, with Aura announcing a Resource Upgrade in August 2021 of 10% or 5.0 million lb U3O8 bringing the total JORC Resource to 56 Mlbs (at a 100 ppm U3O8 lower cut-off grade).

Aura completed a Definitive Feasibility Study for the Tiris Uranium project in August 2019, with a capital estimate update in 2021, to reflect current global pricing, reconfirming Tiris as one of the lowest capex, lowest operating cost uranium projects.

In October 2021, the Company entered a US$10m Offtake Financing Agreement with Curzon, which includes an additional up to US$10m facility, bringing the maximum available under the agreement to US$20m.

In 2022, Aura will continue to transition from a uranium explorer to uranium producer, to capitalise on the rapidly growing demand for nuclear power as the world continues to shift towards a decarbonised energy system.

Disclaimer Regarding Forward Looking Statements

This ASX announcement ("Announcement") contains various forward-looking statements. All statements other than statements of historical fact are forward-looking statements. Forward-looking statements are inherently subject to uncertainties in that they may be affected by a variety of known and unknown risks, variables and factors which could cause actual values or results, performance or achievements to differ materially from the expectations described in such forward-looking statements. The Company does not give any assurance that the anticipated results, performance or achievements expressed or implied in those forward-looking statements will be achieved.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEFIFVRVAISLIF
Date   Source Headline
27th Oct 20229:10 amRNSHolding(s) in Company
25th Oct 20228:58 amRNSHolding(s) in Company
20th Oct 20228:48 amRNSNew Investor Presentation
19th Oct 20228:25 amRNSAura Continues to Advance Tiris Uranium Project
18th Oct 20227:00 amRNSAppendix 3X
14th Oct 20227:00 amRNSIssue of Equity
6th Oct 202210:04 amRNSRelated Party Transaction
4th Oct 20227:04 amRNSIssue of Equity
4th Oct 20227:00 amRNSTotal Voting Rights
30th Sep 202211:09 amRNS2022 Annual Report
30th Sep 20229:38 amRNSIssue of Equity
23rd Sep 20227:47 amRNSHolding(s) in Company
21st Sep 20229:32 amRNSHolding(s) in Company
19th Sep 20227:21 amRNSDavid Woodall Appointed as MD & CEO
12th Sep 20228:42 amRNSIssue of Equity
9th Sep 20228:22 amRNSHolding(s) in Company
6th Sep 20227:00 amRNSSUBMISSION OF EXPORT PRIOR AUTHORISATION
30th Aug 202211:51 amRNSHolding(s) in Company
25th Aug 20227:55 amRNSHolding(s) in Company
1st Aug 20228:12 amRNSHolding(s) in Company
1st Aug 20227:00 amRNSTotal Voting Rights
29th Jul 20227:42 amRNSQuarterly Report for Period Ending 30 June 2022
20th Jul 20228:46 amRNSIssue of Equity
19th Jul 202211:10 amRNSIssue of Equity
1st Jul 20229:40 amRNSLoan Funded Shares and Total Voting Rights
30th Jun 20227:00 amRNSCAPEX AND OPEX ENGINEERING OPTIMISATION COMMENCED
29th Jun 202211:07 amRNSHolding(s) in Company
27th Jun 20227:00 amRNSHolding(s) in Company
23rd Jun 20227:00 amRNSPilot Tests at Tiris Uranium Project
27th May 20227:00 amRNSDrilling for the Tiris Uranium Resource Upgrade
23rd May 20227:00 amRNSIssue of Equity
18th May 20227:00 amRNSUranium Specialist Patrick Mutz Joins Aura Board
12th May 20224:42 pmRNSSecond Price Monitoring Extn
12th May 20224:36 pmRNSPrice Monitoring Extension
5th May 20227:00 amRNSNew Corporate Presentation
3rd May 20227:40 amRNSIssue of Equity
27th Apr 20227:42 amRNSQuarterly Report for the Period Ending 31 March 22
21st Apr 20227:52 amRNSIssue of Equity
19th Apr 20227:00 amRNSUranium Resource Upgrade Programme Underway
6th Apr 202210:12 amRNSIssue of Equity
1st Apr 20227:00 amRNSIssue of Loan Funded Shares
25th Mar 20227:00 amRNSSupplement to 31 December 2021 Half Year Report
23rd Mar 20229:56 amRNSIssue of Equity
17th Mar 20227:41 amRNSIssue of Equity
17th Mar 20227:30 amRNSCleansing Prospectus
14th Mar 20227:00 amRNSFirm commitments for A$8.8 million placement
9th Mar 20227:52 amRNSASX Trading Halt
8th Mar 20228:12 amRNSHalf-year Report
8th Mar 20227:55 amRNSInvestor Webinar
4th Mar 20229:18 amRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.